MR imaging features of thyrotropin-secreting pituitary adenomas at initial presentation

American Journal of Roentgenology

Volumn 181, Issue 2, 2003, Pages 577-582

  Sarlis, Nicholas J ^a,b   Gourgiotis, Loukas ^a   Koch, Christian A ^c,d   Skarulis, Monica C ^a   Brucker Davis, Françoise ^e   Doppman, John L ^f   Oldfield, Edward H ^g   Patronas, Nicholas J ^f  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e Dept of Endocr Med and Diabetes   (France)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; THYROTROPIN;

ADULT; AGED; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; THYROTROPIN RELEASE; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0042845940     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.181.2.1810577     Document Type: Review

References (16)

1. Beck-Peccoz P, Persani L, Mantovani S, Cortelazzi D, Asteria C. Thyrotropin-secreting pituitary adenomas. Metabolism 1996;45[suppl 1]:75-79
2. Lundin P, Bergstrom K, Thuomas KA, Lundberg PO, Muhr C. Comparison of MR imaging and CT in pituitary macroadenomas. Acta Radiol 1991;32:199-1963.
3. Penar PL, Nathan DJ, Nathan MH, Salsali A. Pituitary tumor diagnosis and treatment. Curr Neurol Neurosci Rep 2002;2:236-245
4. Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 1999;84:476-486
5. Buchfelder M. Thyrotroph pituitary adenomas. Endocrinologist 2002;12:117-125
6. Beck-Peccoz P, Brucker-Davis F, Persani L, Small-ridge RC, Weintraub BD. Thyrotropin-secreting pituitary tumors. Endocr Rev 1996;17:610-638
7. Sarlis NJ. Brucker-Davis F, Doppman JL, Skarulis MC. MRI-demonstrable regression of a pituitary mass in a case of primary hypothyroidism after a week of acute thyroid hormone therapy. J Clin Endocrinol Metab 1997;82:808-811
8. Ezzat S, Horvath E, Kovacs K, Smyth HS,. Singer W, Asa SL. Basic fibroblast growth factor expression by two prolactin and thyrotropin-producing pituitary adenomas. Endocr Pathol 1995;6:125-134
9. McCutcheon IE, Weintraub BD, Oldfield EH. Surgical treatment of thyrotropin-secreting pituitary adenomas. J Neurosurg 1990;73:674-683
10. Saad B, Liu A, Brucker-Davis F, Spencer C, Lo-Presti J, Nicoloff J. Simplified screening test for resistance to thyroid hormone (RTH): the T3 challenge test (T3CT). 77th Annual scientific meeting of The Endocrine Society, Washington, DC: The Endocrine Society, 1995;211:1-396
11. Beck-Peccoz P, Medri G, Piscitelli G, et al. Treatment of inappropriate secretion of thyrotropin with somatostatin analog SMS 201-995. Horm Res 1988;29:121-123
12. Webb SM, Ruscalleda J, Schwarzstein D. et al. Computerized tomography versus magnetic resonance imaging: a comparative study in hypothalamic-pituitary and parasellar pathology. Clin Endocrinol (Oxf) 1992;36:459-465
13. Yamada S, Takada K, Ozawa Y, et al. The results of transsphenoidal surgery for 44 consecutive acromegalic patients. Endocr J 1997;44:395-402
14. Stewart PM, James RA. The future of somatostatin analogue therapy. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13:409-418
15. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem 1996;42:140-145
16. Kourides IA. Inappropriate secretion of thyroid-stimulating hormone. Curr Ther Endocrinol Metab 1997;6:52-56